Minodronic acid-d4 structure
|
Common Name | Minodronic acid-d4 | ||
---|---|---|---|---|
CAS Number | 1807367-80-1 | Molecular Weight | 326.17 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C9H8D4N2O7P2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Minodronic acid-d4Minodronic acid-d4 is deuterium labeled Minodronic acid. Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2]. |
Name | Minodronic acid-d4 |
---|
Description | Minodronic acid-d4 is deuterium labeled Minodronic acid. Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C9H8D4N2O7P2 |
---|---|
Molecular Weight | 326.17 |